Organogenesis Holdings
ORGO
28 hedge funds and large institutions have $214M invested in Organogenesis Holdings in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
500% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 2
57% more capital invested
Capital invested by funds: $136M → $214M (+$77.4M)
56% more funds holding
Funds holding: 18 → 28 (+10)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GL
Governors Lane
New York
|
+$15.1M |
| 2 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$14.9M |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$14.8M |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$13.5M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$10M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$2.78M |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.97M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.54M |
| 4 |
AIM
Assured Investment Management
New York
|
-$1.12M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$299K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Hudson Bay Capital Management
Stamford,
Connecticut
| $309K | +$307K | +30,890 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $12K | +$11.7K | +1,176 | New |
|
28
UBS Group
Zurich,
Switzerland
| $5K | – | – | – |
|
|
MIM
29
Monashee Investment Management
Boston,
Massachusetts
| – | -$1.97M | -200,000 | Closed |
|
|
HCMT
30
Highland Capital Management (Texas)
Dallas,
Texas
| – | -$299K | -30,400 | Closed |
|
ORGO Hedge Fund Activity: Q3 2017 in Review
28 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q3 2017, worth a combined $214M — up 57% from $136M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ORGO positions and 2 closed out — a net gain of 10 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Governors Lane, opening a new position worth an estimated $15.1M. The largest seller was Longfellow Investment Management, cutting an estimated $2.78M.
- 28 institutional investors held Organogenesis Holdings (ORGO) as of Q3 2017, up from 18 in Q2 2017.
- Funds reported $214M of Organogenesis Holdings stock for Q3 2017, up 57% quarter-over-quarter.
- 12 funds opened new Organogenesis Holdings positions in Q3 2017 and 2 closed out, a net change of +10 holders.
- The largest Organogenesis Holdings buyer in Q3 2017 was Governors Lane, an estimated $15.1M added.
- The largest Organogenesis Holdings seller in Q3 2017 was Longfellow Investment Management, an estimated $2.78M sold.
Based on aggregated 13F filings for Q3 2017.